GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (FRA:2J6) » Definitions » Debt-to-Equity

MPX International (FRA:2J6) Debt-to-Equity : 3.64 (As of Mar. 2022)


View and export this data going back to 2019. Start your Free Trial

What is MPX International Debt-to-Equity?

MPX International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €5.95 Mil. MPX International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €12.18 Mil. MPX International's Total Stockholders Equity for the quarter that ended in Mar. 2022 was €4.97 Mil. MPX International's debt to equity for the quarter that ended in Mar. 2022 was 3.64.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MPX International's Debt-to-Equity or its related term are showing as below:

FRA:2J6's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

MPX International Debt-to-Equity Historical Data

The historical data trend for MPX International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International Debt-to-Equity Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Debt-to-Equity
0.04 0.03 0.32 1.07

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.59 1.07 1.44 3.64

Competitive Comparison of MPX International's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPX International's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MPX International's Debt-to-Equity falls into.



MPX International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MPX International's Debt to Equity Ratio for the fiscal year that ended in Sep. 2021 is calculated as

MPX International's Debt to Equity Ratio for the quarter that ended in Mar. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MPX International  (FRA:2J6) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


MPX International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MPX International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


MPX International (FRA:2J6) Business Description

Traded in Other Exchanges
N/A
Address
5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

MPX International (FRA:2J6) Headlines

No Headlines